Trump Administration Bans Disease Experts from Speaking to WHO About Growing Ebola Outbreak: Report

**U.S. Disease Experts Require Approval to Contact WHO Amid Retreat from Global Health Leadership**

In a significant shift in policy, experts from key U.S. federal health agencies now require prior approval from senior officials before engaging with the World Health Organization (WHO). This adjustment follows the United States’ withdrawal from the WHO in 2025, alongside substantial cuts to international health funding under the Trump administration’s agenda.

According to a report by CNN, the National Institute of Allergy and Infectious Diseases (NIAID) has implemented strict measures that restrict communications with WHO officials. The directive reportedly mandated that NIAID scientists obtain permission from senior staff before participating in any discussions with the global health body, which includes 194 member nations dedicated to addressing worldwide health challenges.

The limitations on communication were first instituted during the hantavirus outbreak and have since been applied to the current Ebola situation. Following a recent outbreak in the Democratic Republic of Congo, U.S. experts were permitted to attend WHO meetings only in a “listening capacity.” A May 18 email sourced by CNN indicated that meetings would be closely monitored and limited to small groups of up to three experts, who could bring forth research questions through appropriate channels.

In a subsequent development, the number of U.S. representatives allowed to attend WHO meetings has reportedly been increased from three to thirty, reflecting a minor easing of communication restrictions. Nonetheless, these measures underscore a broader trend of withdrawal from active U.S. involvement in international health initiatives.

This recent pivot away from global health leadership was initiated by President Donald Trump on his first day in office when he signed an executive order to withdraw from the WHO. This decision came alongside a reduction in funding for humanitarian initiatives, including the U.S. Agency for International Development (USAID). Notably, the Democratic Republic of Congo, which has been affected by the latest Ebola outbreak, was among the largest beneficiaries of USAID funding before these cuts.

Compounding concerns within the U.S. health landscape is the absence of permanent leadership at several critical agencies. Notably, both the Centers for Disease Control and Prevention (CDC) and NIAID, as well as the Food and Drug Administration (FDA), currently lack appointed directors. Furthermore, positions for Surgeon General and Deputy Health Secretary remain unfilled.

Experts caution that the U.S.’s diminished role in global health could have serious repercussions. Matthew Kavanagh, Director of the Center for Global Health Policy and Politics at Georgetown University, remarked on the longstanding impact of U.S. intervention on preventing potential global outbreaks in previous years. He expressed concern that the response to the ongoing Ebola outbreak was notably delayed, saying, “This outbreak should have been detected weeks ago… it certainly says that the United States has stopped playing a role.”

The implications of these policy shifts may pose significant challenges as the international community grapples with a range of health crises. Critics argue that effective global health governance relies heavily on collaborative efforts and leadership from powerful nations like the United States. The current state of affairs raises questions about the future of international public health initiatives and the U.S.’s capacity to respond to emerging threats.

The situation continues to develop as health experts await further clarity on U.S. engagement with the WHO and the implications for global health cooperation. Observers are keen to see how American policy will adapt in the face of ongoing health challenges that require a coordinated global response.

In light of these changes, stakeholders within both the U.S. and international health communities are hoping for a return to a more collaborative stance in addressing global health crises, which, if unchecked, could threaten the stability of public health worldwide.